Perceptronix Receives C Mark For Its ClearSign(TM) Sputum Test For Early Lung Cancer

Perceptronix Medical Inc. ("Perceptronix") announces receipt of C Mark for its ClearSign™ Sputum Test for the detection of early lung cancer, allowing it to be marketed in the European Union.